A cytotoxic nonstructural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression
- 1 December 1996
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 70 (12) , 8485-91
- https://doi.org/10.1128/jvi.70.12.8485-8491.1996
Abstract
We examined the biological function of a nonstructural regulatory protein, NS1, of human parvovirus B19. Because of the cytotoxic activity of NS1, human hematopoietic cell lines, K562, Raji, and THP-1, were established as transfectants which produce the viral NS1 protein upon induction by using bacterial lactose repressor/operator system. NS1 was significantly produced in the three transfectant cells in an inducer dose- and time-dependent manner. Surprisingly, these three transfectants secreted an inflammatory cytokine, interleukin-6 (IL-6), in response to induction. However, no production of other related cytokines, IL-1beta, IL-8, or tumor necrosis factor alpha, was seen. Moreover, NS1-primed IL-6 induction was transiently demonstrated in primary human endothelial cells. Analysis with luciferase reporter plasmids carrying IL-6 promoter mutant fragments demonstrated that NS1 effect is mediated by a NF-kappaB binding site in the IL-6 promoter region, strongly implying that NS1 functions as a trans-acting transcriptional activator on the IL-6 promoter. Our novel finding, IL-6 induction by NS1, supports the possible relationship between parvovirus B19 infection and polyclonal activation of B cells in rheumatoid arthritis and indicates that NS1 protein may play a significant role in the pathogenesis of some B19-associated diseases by modulating the expression of host cellular genes.Keywords
This publication has 32 references indexed in Scilit:
- INTERLEUKIN-6 (IL-6) INDUCES THE PROLIFERATION OF SYNOVIAL FIBROBLASTIC CELLS IN THE PRESENCE OF SOLUBLE IL-6 RECEPTORRheumatology, 1995
- Human T cell lymphotropic virus type I and cutaneous T cell leukemia/lymphoma.The Journal of Experimental Medicine, 1994
- The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein.The Journal of Experimental Medicine, 1994
- Trans-activation of the long terminal repeat of human immunodeficiency virus type 1 by the parvovirus B19 NS1 gene productJournal of General Virology, 1993
- Interleukin 6 and autoimmunity and plasma cell neoplasiasResearch in Immunology, 1992
- Clonal frequency analysis of B cells producing pathogenic anti-DNA antibody-associated idiotypes in systemic lupus erythematosusClinical Immunology and Immunopathology, 1992
- Interleukin-1 receptor antagonist (IL-1ra) as a probe and as a treatment for IL-1 mediated diseaseInternational Journal of Immunopharmacology, 1992
- Biological and clinical aspects of interleukin 6Immunology Today, 1990
- Pure Red-Cell Aplasia of 10 Years' Duration Due to Persistent Parvovirus B19 Infection and Its Cure with Immunoglobulin TherapyNew England Journal of Medicine, 1989
- Lac repressor can regulate expression from a hybrid SV40 early promoter containing a lac operator in animal cellsCell, 1987